REQUEST A DEMO
Total
USD $0.00
Search more companies

Cms Clinical Research Private Limited (India)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Cms Clinical Research Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Cms Clinical Research Private Limited is an unlisted company, incorporated on 28/11/2014. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U73100TG2014PTC096599 and registration number is 096599. The company is a hospital and medical care company, it is engaged in other hospital and medical care activities.

Headquarters
Flat No.312Sy No.56 Potlapally Residencymiyapur Hyderabad In-Ts In 500041
Hyderabad; Telangana; Postal Code: 500041

Contact Details: Purchase the Cms Clinical Research Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Cms Clinical Research Private Limited report to view the information.
Registered Capital:
Purchase the Cms Clinical Research Private Limited report to view the information.
Incorporation Date:
November 28, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Cms Clinical Research Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-72.88%
Total operating revenue
-68.93%
Operating profit (EBIT)
-73.43%
EBITDA
-72.56%
Net Profit (Loss) for the Period
-73.91%
Total assets
1.6%
Total equity
10.35%
Operating Profit Margin (ROS)
-1.51%
Net Profit Margin
-2.06%
Return on Equity (ROE)
-31.2%
Quick Ratio
0.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?